Friday, July 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “saline” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 23
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 23 pipeline programs matching "saline" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

23 results for “saline” Back to intelligence hub

Search results

  1. 2025-I2M-C&T-B-090B

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumocystis Jiroveci Pneumonia

    phase 3 small molecule active

    1 trial
  2. Agitated Saline SoC

    BRIGHT MINDS BIOSCIENCES INC.

    Right-To-Left Shunt

    phase 3 small molecule active

    1 trial
  3. Normal Saline

    The First People's Hospital of Lianyungang

    Postoperative Sleep Disturbance

    phase 3 small molecule active

    1 trial
  4. SALINE, Fazirsiran

    Takeda

    Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

    phase 3 small molecule active

    1 trial
  5. placebo (saline)

    Sanofi Pasteur

    Sphingomyelin Lipidosis

    phase 3 small molecule completed

    1 trial
  6. NoV Placebo-matching Saline

    Takeda

    Healthy Volunteers

    phase 2 mab completed

    1 trial
  7. Phosphate buffered saline for SC administration

    Alnylam Netherlands B.V.

    Type 2 Diabetes Mellitus

    phase 2 small molecule active

    1 trial
  8. Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept

    Regeneron UK Limited

    Thyroid Eye Disease

    phase 2 small molecule completed

    1 trial
  9. Vialed Saline Placebo, ALXN2030

    Alexion Europe SAS

    Antibody-Mediated Rejection after Kidney Transplantation

    phase 2 small molecule active

    1 trial
  10. phosphate buffered saline., FX06

    Lacuna Pharma Pty Ltd

    Acute Respiratory Distress Syndrome (ARDS)

    phase 2 small molecule active

    1 trial
  11. phosphate-buffered saline for SC administration

    Alnylam Netherlands B.V.

    Hereditary Hemorrhagic Telangiectasia (HHT)

    phase 2 small molecule active

    1 trial
  12. sterile saline solution (0.9% w/v solution of NaCl in water).

    GlaxoSmithKline

    Urinary Tract Infections

    phase 2 small molecule active

    1 trial
  13. Nicotine saline infusion 0.00mcg/kg/s

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial
  14. Normal Saline (NS) .9% 10 mL Injection

    Blackmores Limited

    Ovarian Failure

    phase 1 small molecule active

    1 trial
  15. Saline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 1 small molecule completed

    1 trial
  16. Group C : Saline + propofol group

    Hospital Authority, Hong Kong

    Urologic Surgery

    approved small molecule completed

    1 trial
  17. Normal Saline

    Nanjing Zenshine Pharmaceuticals

    Breast Feeding

    approved small molecule completed

    1 trial
  18. Normal saline

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial
  19. SALINE, TRANEXAMIC ACID

    Disc Medicine

    Slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)

    approved small molecule active

    1 trial
  20. Tranexamic Acid 1000 mg/10ml normal saline infusion

    United Therapeutics Europe Ltd

    Postpartum Hemorrhage

    approved small molecule terminated

    1 trial
  21. 0.9% NaCl physiological saline

    Hospital Authority, Hong Kong

    Acute Respiratory Tract Infections

    small molecule active

    1 trial
  22. Normal Saline (Placebo)

    The First People's Hospital of Lianyungang

    Disease of Respiratory System

    small molecule completed

    1 trial
  23. saline

    United Therapeutics Europe Ltd

    Chorioamnionitis

    small molecule terminated

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.